The FDA has approved the at-home use of FluMist, a nasal spray flu vaccine, available in fall 2025. Effective for healthy people aged 2 to 49, it offers a needle-free option but isn't suitable for ...

Enter: FluMist, the newly FDA-approved at-home nasal flu vaccine. FluMist itself isn't new, but the vaccine can now be ...

FluMist, the nasal flu vaccine spray, was approved in September by the U.S. Food and Drug Administration for at-home use starting in fall 2025. Currently, it can only be administered by a healthcare ...

AstraZeneca says FluMist has been shown to be as effective as other flu vaccines. When the FDA announced last year that it was reviewing the possibility of a self-administered flu vaccine, ...

FluMist is the only non-injected flu vaccine available to people in the U.S. For the 2024-2025 flu season, FluMist and all of the other approved vaccines will guard against three subtypes of flu: ...

The advisory panel first voted, with one abstention, to back the usual U.S. recommendation that nearly everyone age 6 months ...

FluMist prevents cases of the flu caused by influenza virus subtypes A and B. It can be administered to people between the ages of 2 and 49. The nasal flu vaccine is not an entirely new medication ...

WILMINGTON, Del., September 20, 2024--FLUMIST® has been approved in the US as the only self-administered influenza vaccine. FLUMIST, a needle-free nasal spray, was approved to be self ...

The U.S. Food and Drug Administration has approved FluMist — the nasal spray flu vaccine — for home use by a patient or adult caregiver. Dr. Nicole Saphier and Dr. Marc Siegel weigh in.

FluMist was first approved for at-home use in September by the U.S. Food and Drug Administration. Right now, only healthcare providers can administer the spray.

FluMist (influenza vaccine live, intranasal) is a brand-name vaccine that’s used to help prevent influenza infection (the flu) in adults and some children. FluMist comes as a nasal spray that ...